Cyclin A Antikörper
-
- Target Alle Cyclin A (CCNA2) Antikörper anzeigen
- Cyclin A (CCNA2) (Cyclin A2 (CCNA2))
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Cyclin A Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), ELISA, Immunocytochemistry (ICC)
- Spezifität
- Cyclin A antibody detects endogenous levels of total Cyclin A
- Kreuzreaktivität
- Human, Maus, Ratte (Rattus)
- Aufreinigung
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
- Immunogen
- A synthesized peptide derived from human Cyclin A
- Isotyp
- IgG
- Top Product
- Discover our top product CCNA2 Primärantikörper
-
-
- Applikationshinweise
- WB: 1:500~1:3000 IHC: 1:50~1:200 IF/ICC: 1:100~1:500
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C.Stable for 12 months from date of receipt
- Haltbarkeit
- 12 months
-
-
The receptor for activated protein kinase C promotes cell growth, invasion and migration in cervical cancer." in: International journal of oncology, Vol. 51, Issue 5, pp. 1497-1507, (2018) (PubMed).
: "Ovostatin 2 knockdown significantly inhibits the growth, migration, and tumorigenicity of cutaneous malignant melanoma cells." in: PLoS ONE, Vol. 13, Issue 4, pp. e0195610, (2018) (PubMed).
: "CD38 enhances the proliferation and inhibits the apoptosis of cervical cancer cells by affecting the mitochondria functions." in: Molecular carcinogenesis, Vol. 56, Issue 10, pp. 2245-2257, (2017) (PubMed).
: "Vascular endothelial growth factor C enhances cervical cancer migration and invasion via activation of focal adhesion kinase." in: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, Vol. 29, Issue 1, pp. 20-4, (2013) (PubMed).
: "
-
The receptor for activated protein kinase C promotes cell growth, invasion and migration in cervical cancer." in: International journal of oncology, Vol. 51, Issue 5, pp. 1497-1507, (2018) (PubMed).
-
- Target
- Cyclin A (CCNA2) (Cyclin A2 (CCNA2))
- Andere Bezeichnung
- Cyclin A (CCNA2 Produkte)
- Synonyme
- CCN1 antikoerper, CCNA antikoerper, AA408589 antikoerper, Ccn-1 antikoerper, Ccn1 antikoerper, Ccna antikoerper, CycA2 antikoerper, Cyca antikoerper, cb671 antikoerper, chunp6924 antikoerper, wu:fi36f03 antikoerper, CYCA antikoerper, Cyclin-A2 antikoerper, ccna2 antikoerper, ccn1 antikoerper, ccna antikoerper, ccna1 antikoerper, Cyclin-A antikoerper, cyclinA antikoerper, cyclin A2 antikoerper, cyclin A2 S homeolog antikoerper, cyclin A2 L homeolog antikoerper, CCNA2 antikoerper, Ccna2 antikoerper, ccna2 antikoerper, ccna2.S antikoerper, ccna2.L antikoerper
- Hintergrund
-
Description: May be involved in the control of the cell cycle at the G1/S (start) and G2/M (mitosis) transitions. May primarily function in the control of the germline meiotic cell cycle and additionally in the control of mitotic cell cycle in some somatic cells.
Gene: CCNA1
- Molekulargewicht
- 53kDa
- Gen-ID
- 8900
- UniProt
- P78396, P20248
- Pathways
- PI3K-Akt Signalweg, Zellzyklus, AMPK Signaling, Mitotic G1-G1/S Phases, DNA Replication, M Phase, Synthesis of DNA
-